Clinical Trial Update: Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated the safety and efficacy of autologous hair follicle cell therapy for androgenetic alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Autologous hair follicle cell therapy

Snippet

Sponsor: TrichoScience Innovations, Inc. | Conditions: Androgenetic Alopecia | Phase 1, Phase 2 | Status: COMPLETED